Apogee Acquisition Corp Class A AACP 深 滬
已收盤 08-07 16:00:00 美东时间
10.00
-0.010
-0.10%
華盛通- 最 高10.01
- 今 開10.01
- 成交量 5.32万股
- 最 低 10.00
- 昨 收 10.01
- 總市值 23.47万
- 52周最高 10.02
- 市盈率 靜 --
- 換手率 226.71%
- 52周最低 9.93
- 委 比 -36.83%
- 總股本 2.35万
- 歷史最高 10.02
- 量 比 2.00
- 振 幅 0.10%
- 歷史最低 9.93
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
Apogee Therapeutics announced positive results from the Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis (AD), meeting primary and secondary endpoints with high statistical significance. Mid-dose zumilokibart showed the best clinical activity and tolerability, with plans for Phase 3 trials in 2H 2026. The drug demonstrated potential for less frequent dosing and robust efficacy, with plans to expand into asthma and eosino...
05-27 10:30
